eyeforpharma Ltd, headquartered at 7-9 Fashion Street, London, E1 6PX, United Kingdom. A registered company in England and Wales: 09823909. | Terms and conditions
Will GSK’s new ‘ethical’ approach to its customers deliver commercial success?
In a bid to overcome stubborn industry-wide challenges, improve external perceptions and build stronger relationships with customers, GSK has made innovative changes to age-old, traditional commercial processes.

In this whitepaper we explore the new GSK commercial model and reflect on the impact it’s having on the industry as a whole. Will this new approach become common practice?

Find out more by downloading your free copy today >>>

With expert contributions from:
  • Murray Stewart, Chief Medical Officer, GSK
  • Deborah Waterhouse, SVP and Business Unit Head, GSK
  • Denise Dewar, Head of MCM Excellence, GSK
  • Victoria Williams, VP and Sales Director, GSK FR
  • John Lamattina, former President, Pfizer
  • Stewart Adkins, financial analyst and Director, Pharmaforensic
  • Christopher Bowe, award-winning writer
  • Jack Whelan, cancer survivor and sales expert
Discover how GSK’s business model will change pharma forever, download your copy today >>>

Learn how GSK’s new sales model is transforming pharma